Such great news for Covid patients!
BREAKING: The NIHR-supported @remap_cap trial shows that patients receiving tocilizumab and a second drug called sarilumab can reduce the relative risk of death by 24% when administered to patients within 24 hours of entering intensive care.Β #Covid19 nihr.ac.uk/news/arthritisβ¦View quoted post on X